Clinical Trial Update: Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled trial evaluating cannabinoids for traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Cannabinoids (unspecified formulation) (cannabinoids)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Brain Injuries, Traumatic | Phase 2 | Status: COMPLETED